[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:charcot-marie-tooth-disease-type-2d":3},{"name":4,"total":5,"trials":6,"biomarkers":15,"states":16},"Charcot-Marie-Tooth Disease Type 2D",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07226297","Personalized Antisense Oligonucleotide for A Single Participant With GARS1 Gene Mutation Associated With Charcot-Marie-Tooth Disease Type 2D (CMT2D)",[11],"Phase 1\u002FPhase 2","ENROLLING_BY_INVITATION","2026-08-03T02:05:27.322885Z","2026-06-16T05:54:07.873400Z",[],[]]